-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Heron Therapeutics, Inc. /De/ quarterly/annual Costs and Expenses history and growth rate from 2018 to 2024.
- Heron Therapeutics, Inc. /De/ Costs and Expenses for the quarter ending March 31, 2024 was $31 M, a 32.3% decline year-over-year.
- Heron Therapeutics, Inc. /De/ Costs and Expenses for the twelve months ending March 31, 2024 was $158 M, a 15.6% decline year-over-year.
- Heron Therapeutics, Inc. /De/ annual Costs and Expenses for 2023 was $173 M, a 24.1% decline from 2022.
- Heron Therapeutics, Inc. /De/ annual Costs and Expenses for 2022 was $227 M, a 25.2% decline from 2021.
- Heron Therapeutics, Inc. /De/ annual Costs and Expenses for 2021 was $304 M, a 3.99% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)